BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation

Clinical and Experimental Metastasis

Volumn 29, Issue 4, 2012, Pages 293-313

  Peart, Teresa M ^a,b   Correa, Rohann J M ^a,b   Valdes, Yudith Ramos ^a   DiMattia, Gabriel E ^a,b   Shepherd, Trevor G ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

AKT kinase; ALK3 QD; BMP signalling; Ovarian cancer; Spheroid

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; NOGGIN; PROCOLLAGEN C PROTEINASE; PROTEIN KINASE B INHIBITOR;

ADHESION; ARTICLE; CARCINOMA; CONTROLLED STUDY; DISPERSION; DOWN REGULATION; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OVARY CANCER; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPHEROID CELL; SUSPENSION CELL CULTURE;

ASCITES; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELL ADHESION; ENZYME ACTIVATION; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84859709406     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9451-3     Document Type: Article

References (53)

1. Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053-1064
2. Shield K, Ackland ML, Ahmed N, Rice GE (2009) Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol 113(1):143-148
3. Kim TH, Mount CW, Gombotz WR, Pun SH (2010) The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31(28):7386-7397
4. Grun B, Benjamin E, Sinclair J, Timms JF, Jacobs IJ, Gayther SA, Dafou D (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif 42(2):219-228
5. Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15(5):365-377
6. Herrera B, van Dinther M, Ten Dijke P, Inman GJ (2009) Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res 69(24):9254-9262
7. Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM (2009) BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2:4
8. Ma Y, Ma L, Guo Q, Zhang S (2010) Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res 29:85
9. Moll F, Millet C, Noel D, Orsetti B, Bardin A, Katsaros D, Jorgensen C, Garcia M, Theillet C, Pujol P, Francois V (2006) Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. FASEB J 20(2):240-250 (Pubitemid 44933171)
10. Pils D, Wittinger M, Petz M, Gugerell A, Gregor W, Alfanz A, Horvat R, Braicu EI, Sehouli J, Zeillinger R, Mikulits W, Krainer M (2010) BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment. Gynecol Oncol 117(2):189-197
11. Shepherd TG, Mujoomdar ML, Nachtigal MW (2010) Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion. J Ovarian Res 3:5
12. Shepherd TG, Theriault BL, Nachtigal MW (2008) Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 414(1-2):95-105
13. Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW (2007) BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28(6):1153-1162 (Pubitemid 47062673)
14. Dunfield LD, Dwyer EJ, Nachtigal MW (2002) TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells. Endocrinology 143(4):1174-1181 (Pubitemid 34274344)
15. Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT, Donahoe PK (2010) Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci USA 107(44):18874-18879
16. Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW (2006) Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 1(6):2643-2649
17. Shepherd TG, Nachtigal MW (2003) Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 144(8):3306-3314 (Pubitemid 36904404)
18. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T (2003) Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14(7):2809-2817 (Pubitemid 36871523)
19. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400(6745):687-693
20. Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31(6):1403-1413
21. Boergermann JH, Kopf J, Yu PB, Knaus P (2010) Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. Int J Biochem Cell Biol 42(11):1802-1807
22. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 18(15):4388-4392
23. Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nature reviews 7(1):54-60
24. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929-1935 (Pubitemid 44497995)
25. Zhang SD, Gant TW (2008) A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics 9:258
26. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63(1):196-206 (Pubitemid 36070440)
27. Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nature reviews 9(6):415-428
28. Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG (2011) Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis 33(1):49-58
29. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH (2006) Role of PI3 K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18(12):2262-2271 (Pubitemid 44636166)
30. Ahmed N, Thompson EW, Quinn MA (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213(3):581-588 (Pubitemid 350058249)
31. Tang MK, Zhou HY, Yam JW, Wong AS (2010) c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 12(2):128-138
32. Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250(2):231-250 (Pubitemid 35216412)
33. Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J Biol Chem 282(28):20603-20611 (Pubitemid 47100044)
34. Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J 20(15):4132-4142 (Pubitemid 32751829)
35. Kamiya Y, Miyazono K, Miyazawa K (2010) Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction. J Biol Chem 285(40):30804-30813
36. Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE, Skubitz AP (2001) Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 159(6):2071-2080 (Pubitemid 33104261)
37. Kim YJ, Sauer C, Testa K, Wahl JK, Svoboda RA, Johnson KR, Wheelock MJ, Knudsen KA (2005) Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci 118(Pt 17):3883-3894 (Pubitemid 41410272)
38. Napolitano AP, Chai P, Dean DM, Morgan JR (2007) Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng 13(8):2087-2094 (Pubitemid 47294004)
39. Tzanakakis ES, Hansen LK, Hu WS (2001) The role of actin filaments and microtubules in hepatocyte spheroid self-assembly. Cell Motil Cytoskeleton 48(3):175-189 (Pubitemid 32181928)
40. Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F (2008) BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 121(Pt 23):3960-3970
41. Burleson KM, Boente MP, Pambuccian SE, Skubitz AP (2006) Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med 4:6
42. Iwanicki M, Davidowitz R, Ng M, Besser A, Muranen T, Merritt M, Danuser G, Ince T, Brugge J (2011) Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. doi:10.1158/2159-8274.CD-11-0010
43. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577-584 (Pubitemid 37280136)
44. Guo X, Wang XF (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19(1):71-88
45. Perez VA, Ali Z, Alastalo TP, Ikeno F, Sawada H, Lai YJ, Kleisli T, Spiekerkoetter E, Qu X, Rubinos LH, Ashley E, Amieva M, Dedhar S, Rabinovitch M (2011) BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. J Cell Biol 192(1):171-188
46. Chen X, Liao J, Lu Y, Duan X, Sun W (2011) Activation of the PI3 K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Pathol Oncol Res 17(2):257-261
47. Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB (2009) PI3 K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate 69(2):168-180
48. Kang MH, Kang HN, Kim JL, Kim JS, Oh SC, Yoo YA (2009) Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep 22(3):525-534
49. Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA (2010) BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3 K)/Akt pathway. Exp Cell Res 316(1):24-37
50. Langenfeld EM, Kong Y, Langenfeld J (2005) Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Mol Cancer Res 3(12):679-684 (Pubitemid 43042997)
51. Davidson B, Espina V, Steinberg SM, Florenes VA, Liotta LA, Kristensen GB, Trope CG, Berner A, Kohn EC (2006) Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 12(3 Pt 1):791-799 (Pubitemid 43259859)
52. Schilder RJ, Sill MW, Lee RB, Shaw TJ, Senterman MK, Klein-Szanto AJ, Miner Z, Vanderhyden BC (2008) Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 26(20):3418-3425
53. Massague J (2008) TGFbeta in Cancer. Cell 134(2):215-230